BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25122803)

  • 1. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
    Rowe M; Raithatha S; Shannon-Lowe C
    J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
    Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.
    Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III.
    Messinger JE; Dai J; Stanland LJ; Price AM; Luftig MA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.
    Campion EM; Hakimjavadi R; Loughran ST; Phelan S; Smith SM; D'Souza BN; Tierney RJ; Bell AI; Cahill PA; Walls D
    J Virol; 2014 May; 88(9):5001-13. PubMed ID: 24554662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
    Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters.
    Höfelmayr H; Strobl LJ; Stein C; Laux G; Marschall G; Bornkamm GW; Zimber-Strobl U
    J Virol; 1999 Apr; 73(4):2770-80. PubMed ID: 10074124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
    Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
    J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
    Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
    Yoo L; Speck SH
    J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
    Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
    J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBNA2 and activated Notch induce expression of BATF.
    Johansen LM; Deppmann CD; Erickson KD; Coffin WF; Thornton TM; Humphrey SE; Martin JM; Taparowsky EJ
    J Virol; 2003 May; 77(10):6029-40. PubMed ID: 12719594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.